Georgetown University Medical Center is a biomedical research and educational organization that responsible for over 80% of Georgetown University's sponsored research funding and is led by Edward B. Healton, MD, the Executive Vice President for Health Sciences and Executive Dean of the School of Medicine. The medical center adjoins Georgetown University Hospital on the university's main campus in Washington, DC. It encompasses four sectors of medical education and research: Georgetown University School of Medicine, the School of Nursing and Health Studies, Georgetown Lombardi Comprehensive Cancer Center, and the Biomedical Graduate Research Organization. School of Medicine Founded in 1851, the School of Medicine is committed to educating medical students in the spirit of the Jesuit ideal of cura personalis, or "care of the whole person." Ranked among the top 50 medical schools in the country, in 2008 the school was ranked 40th by U.S. News & World Report. The school of Medicine is led by the Dean for Medical Education, Stephen Ray Mitchell, MD. School of Nursing & Health Studies The School of Nursing & Health Studies is one of the four undergraduate schools at Georgetown University, and consists of four academic departments: Health Care Management and Policy, Human Science, Global Health, and Nursing. The School of Nursing & Health Studies also has 233 students in its nine graduate programs, including the Nurse Anesthesia program, ranked sixth in the nation. Carole Roan Gresenz, Ph.D., is the Interim Dean of the School of Nursing and Health Studies. Lombardi Comprehensive Cancer Center Lombardi Comprehensive Cancer Center is the only comprehensive cancer center accredited by the National Cancer Institute (NCI) in the Washington, DC region, and one of only 41 nationwide. Named for Green Bay Packers and Washington Redskins coach Vince Lombardi, who was treated at Georgetown, Lombardi was established in 1970 as the cancer clinic at Georgetown University Hospital. Today, Lombardi has over 200 faculty and receives $100 million in research funding each year. The director of the Lombardi Comprehensive Cancer Center is Dr. Louis M. Weiner, MD, and notable faculty include Dr. Richard Schlegel, one of the innovators behind the HPV vaccine and Conditionally Reprogrammed Cells (CRC) technology. Biomedical Graduate Research Organization The Biomedical Graduate Research Organization is responsible for more than 60% of the sponsored research conducted at the medical center. Its mission includes both basic science departments and clinical departments, as well as graduate education in the biomedical sciences. The